Voclosporin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 169 publications
The role of monoclonal antibodies in the treatment of lupus nephritis.
Journal: Expert opinion on biological therapy
Published: April 07, 2026
Obinutuzumab (Gazyva) for lupus nephritis.
Journal: The Medical letter on drugs and therapeutics
Published: March 07, 2026
High-Dose Voclosporin Protects Against Acute Kidney Injury via Regnase-2-Mediated NGAL MRNA Decay.
Journal: International journal of molecular sciences
Published: March 04, 2026
Single-center experience of voclosporin use for pediatric lupus nephritis: a case series.
Journal: Rheumatology (Oxford, England)
Published: February 27, 2026
Pathogenesis, Treatment Advances, and Renal Outcomes in Childhood-Onset Lupus Nephritis.
Journal: Clinical pediatrics
Published: February 19, 2026
Two-Hour Post-dose (C2)-Monitored Cyclosporine Microemulsion as a Practical Alternative to Voclosporin in Mixed Class IV/V Lupus Nephritis: A Case Report.
Journal: Cureus
Published: January 29, 2026
Recent advances in immunosuppressive therapy for lupus nephritis.
Journal: Immunological medicine
Published: January 07, 2026
Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis.
Journal: Frontiers in medicine
Published: November 20, 2025
Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.
Journal: Reumatismo
Published: October 24, 2025
Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.
Journal: Immunopharmacology and immunotoxicology
Published: October 16, 2025
Systemic Lupus Erythematosus: Ophthalmological Safety Considerations of Emerging and Conventional Therapeutic Agents.
Journal: International journal of molecular sciences
Published: October 07, 2025
Last Updated: 04/28/2026